Elucidating the role and regulation of periostin in therapy-induced chemoresistance in metastatic breast cancer
阐明骨膜素在转移性乳腺癌化疗耐药中的作用和调节
基本信息
- 批准号:10408263
- 负责人:
- 金额:$ 10.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2022-03-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAdherent CultureAutomobile DrivingBT 474BioinformaticsBreast Cancer CellBreast Cancer PatientBreast Cancer cell lineBreast Cancer therapyCancer Cell GrowthCell Culture TechniquesCell ProliferationCell SurvivalCellsCessation of lifeChemoresistanceClustered Regularly Interspaced Short Palindromic RepeatsCoculture TechniquesCultured CellsDataDiseaseDisease remissionDistantDistant MetastasisDrug resistanceEssential GenesFemaleFibroblastsFundingFutureGene TargetingGenesGrantGuide RNAHumanIn VitroInvestigationK-Series Research Career ProgramsKnowledgeLaboratoriesLibrariesLinkLungMalignant NeoplasmsMediatingMentored Research Scientist Development AwardMetastatic breast cancerModelingNeoplasm MetastasisNon-MalignantParentsPathway AnalysisPharmaceutical PreparationsPhenotypePrimary NeoplasmProcessProteinsRecurrenceRegulationResistanceRoleSignal PathwaySiteStromal CellsSystemic TherapyT47DTestingUnited StatesWomanWorkbasebreast cancer survivalcancer cellcancer therapycell typechemotherapyexperimental studygenome wide screengenome-widehormone receptor-positivein vitro Modelin vivolung metastaticmalignant breast neoplasmmolecular subtypesmortalityneoplastic cellnew therapeutic targetnovelperiostinresponsetriple-negative invasive breast carcinomatumortumor growthtumor microenvironmenttumorigenesis
项目摘要
Project Summary
Approximately 450,000 women succumb to breast cancer each year, making it the most common
cause of female cancer mortality globally, with the majority of these deaths resulting from metastatic disease.
In the treatment of metastases, the initial drug response rate is only about 50%, as compared to 90% observed
in the treatment of primary tumors. Furthermore, resistance to these systemic therapies typically develops
more quickly in the metastatic setting. While numerous studies have focused on tumor cell intrinsic
mechanisms of metastasis and drug resistance, there have been very few investigations into how non-
malignant host cells of the metastatic tumor microenvironment extrinsically promote these processes.
Fibroblasts are one cell type present in the tumor microenvironment which have been linked to several tumor
growth and metastasis promoting activities. Despite this emerging paradigm, very few studies have evaluated
the contributions of lung fibroblasts to extrinsic mechanisms of cancer cell survival and chemo-resistance, a
reflection of the difficulty of conducting these investigations in vivo, and the paucity of in vitro models which
reliably recapitulate in vivo tumor-stroma interactions. Our laboratory has fully optimized a 3D lung-like
organotypic co-culture model which effectively incorporates both tumor cells and primary resident stromal cells
from secondary sites of metastasis. Utilizing this model, our preliminary data demonstrate that lung fibroblasts
modulate significant phenotypic differences in human breast cancer cell proliferation and drug response, in a
breast cancer molecular-subtype dependent manner. Based on these data, we hypothesize that we can
identify tumor cell specific genes whose function is essential for their attainment of pro-survival and drug
resistant phenotypes upon interaction with lung fibroblasts. To investigate this, we propose to conduct a
genome-wide CRISPR “stromal synthetic lethal” screen against human breast cancer cells cultured in the
presence or absence of primary human lung fibroblasts. Results of these studies will fill a critical knowledge
gap regarding lung fibroblast mediated promotion of breast cancer survival and will uncover novel genes
whose function/proteins can be targeted for assessment as potential novel anti-metastatic therapies for breast
cancer.
项目摘要
每年约有45万妇女死于乳腺癌,使其成为最常见的癌症。
癌症是全球女性癌症死亡的主要原因,其中大多数死亡是由转移性疾病引起的。
在转移瘤的治疗中,初始药物反应率仅为约50%,而观察到的反应率为90
原发性肿瘤的治疗。此外,对这些全身治疗的耐药性通常会发展为
在转移性疾病中会更快。虽然许多研究都集中在肿瘤细胞的内在
转移和耐药性的机制,很少有研究如何非-
转移性肿瘤微环境的恶性宿主细胞额外地促进这些过程。
成纤维细胞是存在于肿瘤微环境中的一种细胞类型,其与多种肿瘤相关。
生长和转移促进活性。尽管有这种新兴的模式,很少有研究评估
肺成纤维细胞对癌细胞存活和化疗耐药的外在机制的贡献,
这反映了在体内进行这些研究的困难,以及缺乏体外模型,
可靠地再现体内肿瘤-基质相互作用。我们的实验室已经完全优化了一个3D肺样
有效地合并肿瘤细胞和原代驻留基质细胞的器官型共培养模型
转移的继发部位。利用这个模型,我们的初步数据表明,肺成纤维细胞,
在某种程度上,调节人乳腺癌细胞增殖和药物反应中的显着表型差异
乳腺癌的分子亚型依赖方式。基于这些数据,我们假设我们可以
鉴定肿瘤细胞特异性基因,其功能对于它们获得促存活和药物治疗是必需
耐药表型与肺成纤维细胞相互作用。为了调查这一点,我们建议进行一次
全基因组CRISPR“基质合成致死”筛选培养在
存在或不存在原代人肺成纤维细胞。这些研究的结果将填补关键的知识
关于肺成纤维细胞介导的促进乳腺癌生存的空白,并将发现新的基因
其功能/蛋白质可作为乳腺癌潜在的新型抗转移疗法进行靶向评估
癌
项目成果
期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Rotator cuff repair using a bioresorbable nanofiber interposition scaffold: a biomechanical and histologic analysis in sheep.
- DOI:10.1016/j.jse.2021.07.018
- 发表时间:2022-03
- 期刊:
- 影响因子:3
- 作者:Romeo, Anthony;Easley, Jeremiah;Regan, Dan;Hackett, Eileen;Johnson, James;Johnson, Jed;Puttlitz, Christian;McGilvray, Kirk
- 通讯作者:McGilvray, Kirk
Canine tonsillar neoplasia and tonsillar metastasis from various primary neoplasms.
- DOI:10.1111/vco.12604
- 发表时间:2020-12
- 期刊:
- 影响因子:2.1
- 作者:Mickelson MA;Regan D;Randall EK;Worley D;Seguin B
- 通讯作者:Seguin B
Immunization against full-length protein and peptides from the Lutzomyia longipalpis sand fly salivary component maxadilan protects against Leishmania major infection in a murine model.
- DOI:10.1016/j.vaccine.2017.10.039
- 发表时间:2017-12-04
- 期刊:
- 影响因子:5.5
- 作者:Wheat WH;Arthun EN;Spencer JS;Regan DP;Titus RG;Dow SW
- 通讯作者:Dow SW
Evaluation of lumbar spinal fusion utilizing recombinant human platelet derived growth factor-B chain homodimer (rhPDGF-BB) combined with a bovine collagen/β-tricalcium phosphate (β-TCP) matrix in an ovine model.
- DOI:10.1002/jsp2.1166
- 发表时间:2021-09
- 期刊:
- 影响因子:3.7
- 作者:Gadomski BC;Labus KM;Puttlitz CM;McGilvray KC;Regan DP;Nelson B;Seim HB 3rd;Easley JT
- 通讯作者:Easley JT
Evaluation of Myogenin and MyoD1 as Immunohistochemical Markers of Canine Rhabdomyosarcoma.
- DOI:10.1177/0300985820988146
- 发表时间:2021-05
- 期刊:
- 影响因子:2.4
- 作者:Tuohy JL;Byer BJ;Royer S;Keller C;Nagai-Singer MA;Regan DP;Seguin B
- 通讯作者:Seguin B
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel Patrick Regan其他文献
Daniel Patrick Regan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel Patrick Regan', 18)}}的其他基金
Elucidating the role and regulation of periostin in therapy-induced chemoresistance in metastatic breast cancer
阐明骨膜素在转移性乳腺癌化疗耐药中的作用和调节
- 批准号:
9164338 - 财政年份:2016
- 资助金额:
$ 10.3万 - 项目类别:
Elucidating the role and regulation of periostin in therapy-induced chemoresistance in metastatic breast cancer
阐明骨膜素在转移性乳腺癌化疗耐药中的作用和调节
- 批准号:
9926128 - 财政年份:2016
- 资助金额:
$ 10.3万 - 项目类别:
相似海外基金
Probe-type nanowire sensor for label-free, in-situ, ultrasensitive detection of biomarkers from single cell in adherent culture
探针型纳米线传感器,用于无标记、原位、超灵敏地检测贴壁培养中单细胞的生物标志物
- 批准号:
21K14653 - 财政年份:2021
- 资助金额:
$ 10.3万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
CAREER: Rolled Scaffold for High-Density Adherent Culture of Mammalian Cells
职业:用于哺乳动物细胞高密度贴壁培养的滚动支架
- 批准号:
1848251 - 财政年份:2019
- 资助金额:
$ 10.3万 - 项目类别:
Continuing Grant














{{item.name}}会员




